LAMEA Smart Biopsy Market Size & Forecast Report 2019-2025

LAMEA Smart Biopsy Market By Application (Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others) By Country, Industry Analysis and Forecast, 2019 - 2025

Published Date: November-2019 | Number of Pages: 89 | Format: PDF | Report ID: KBV-12115

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the LAMEA Smart Biopsy Market

Market Report Description

The Latin America, Middle East and Africa Smart Biopsy Market would witness market growth of 5.97% CAGR during the forecast period (2019-2025). Ever-miniaturizing technology in medical imaging has given rise to certain new and exciting opportunities. In recent times, the medical industry has witnessed the development of a complex lens system that fits inside a syringe, an optical sensor that fits for precision guidance at the end of an epidural needle, and a camera-loaded catheter that streams live from inside arteries and even removes plaque simultaneously.

After scientists developed a new "smart needle" that uses a mini laser to identify diseased tissue within seconds, cancer detection would become much faster and easier in the future. Scientists have demonstrated the laboratory functions of the technique and have launched a major three-year clinical trial in 2019 to test it in people. They have so far focused on lymphoma but are hopeful that the technique can also be used to detect other forms of diseases such as breast and prostate cancer further down the line.

Apparently, lymphoma diagnosis can be an invasive process involving a surgical biopsy accompanied by a nerve-wracking wait for the result that can often take two weeks or more. The smart needle uses light to almost instantly identify cancerous tissues. Using a method called Raman spectroscopy, when a laser embedded in the needle reflects on it, the' optical biopsy' measures the light dispersed by tissues. The light is absorbed differently from healthy and diseased tissues, which ensures that doctors will immediately make a diagnosis.

Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: Smart Biopsy Market in LAMEA is expected to register a CAGR of 5.97% during the forecast period (2019-2025)

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.

Scope of the Smart Biopsy Market Analysis

Market Segmentation:

By Application

  • Breast cancer
  • Skin cancer
  • Liver cancer
  • Prostate cancer and
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Danaher Corporation
  • Argon Medical Devices, Inc.
  • Cardinal Health, Inc.
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • B. Braun Melsungen AG
  • Cook Medical, Inc. (Cook Group)
  • Medtronic Plc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Smart Biopsy Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities